Skip to main content
Back to News
RISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum...
Funding
1 min read
US

RISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum...

The AMW Read

Updates the player map for oncology-focused Vertical AI (06) with a new entrant utilizing agentic workflows (02) to solve administrative bottlenecks.
NoveltySignificance
Healthcare & Bio · Player MapAI Agents · Definition

RISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum Ventures to scale its AI operating system for oncology. Its BOSS platform uses autonomous agents to manage complex workflows like prior authorizations across fragmented healthcare systems. By replacing manual paperwork with intelligent automation, the startup eliminates administrative bottlenecks that frequently delay life-saving treatments. This signifies a pivot toward AI agents that independently navigate payer ecosystems to optimize clinical operations. 🚀

#HealthTech #AI #Oncology #VentureCapital #Innovation

How This Connects

Based on Healthcare & Bio · Player Map

  1. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  2. 1mo agoMedipal launches Medipal AI agent platform for specialized clinic operationsMedipal
  3. 1mo agoAmbience Healthcare unveiled a multiyear AI platform roadmap that extends clinical intelligence acro...Ambience Healthcare
  4. 1mo agoSynthpop closed a $15M Series A (total funding $23M) to scale its multi‑agent AI platform that autom...Synthpop
  5. 4mo agoRISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum... · THIS ARTICLE

Related News

More news from Risa Labs Inc.

Stay updated with the latest news and announcements from Risa Labs Inc..

View all Risa Labs Inc. news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard